News
Boring Financials Point Way to Exciting Stock Gains!
We have uncovered 26 different Financial factors that point to stocks likely to beat the market. That’s because they are so effective in finding stocks ready to report earnings beats BEFORE they happen.
a month ago•Steve Reitmeister
Hot or Not, Stock Market Edition: 01/09/2026
What’s hot and what’s not in the market for 1/9/2026, including Agnico Eagle Mines (AEM), OGE Energy (OGE), and more.
a month ago•Jessie Moore
LHX
AEM
NI
OGE
3 Undervalued Stock Winners for 2026
These under-the-radar stocks could be tomorrow’s undervalued winners — including European Wax Center (EWCZ) and more.
a month ago•Lyndon Seitz
IRWD
EWCZ
BVS
3 New Strong Buy Ratings from Top-Rated Analysts: 01/09/2026
3 Strong Buy stocks for 1/9/2025, including Blue Bird (BLBD) and more stocks with excellent A (Strong Buy) Zen Ratings.
a month ago•Jessie Moore
PTC
BLBD
SGHC
A Bet on Online Betting: Our Top Gambling Stock
Forget DraftKings — here’s a gambling stock that has near-term catalysts that could make it surge in 2026.
a month ago•Corbin Buff
DKNG
FLUT
RSI
3 New Strong Buy Ratings from Top-Rated Analysts: 01/08/2026
3 Strong Buy stocks for 1/8/2026, including Neurocrine Biosciences (NBIX) and more. All vetted by our quant ratings system.
a month ago•Jessie Moore
NBIX
VTRS
SUPN
Hot or Not, Stock Market Edition: 01/08/2026
Here’s our roundup of today’s hot and not-so-hot stocks, including Hasbro (HAS) and more.
a month ago•Jessie Moore
HAS
OR
CUBE
CAVA
2 Strong Buy Stocks From Our Top-Performing Portfolio
2025 was a great year. 2026 could be even better for these 2 top-performing stocks.
a month ago•Mijuško Šibalić
AVAH
BWMX
Hot or Not, Stock Market Edition: 01/06/2026
Today’s hot (and not) stocks, including power player Elanco Animal Health (ELAN) and more.
2 months ago•Jessie Moore
ELAN
EXPE
SMCI
PHM
115 Reasons to Snap Up Pacira Biosciences (PCRX) Shares
Pacira Biosciences (PCRX) is an under-the-radar ticker with grand prospects for 2026. Here’s the story.
2 months ago•Mijuško Šibalić
PCRX
3 New Strong Buy Ratings from Top-Rated Analysts: 01/06/2026
3 Strong Buy stocks for 1/6/2026, including Amneal Pharmaceuticals (AMRX) and more
2 months ago•Jessie Moore
AMRX
TEVA
AVGO
Amneal Pharmaceuticals (AMRX): Time to Buy this HEALTHY Growth Stock
Sure you can buy healthcare stocks as a conservative safety blanket. However, every now and then a healthcare growth stock like Amneal (AMRX) comes around that deserves your attention.
2 months ago•Steve Reitmeister
AMRX
Beware Growth Stocks!
Investors love growth stocks. Unfortunately for every success story like NVDA there is a myriad of failures leading to tremendous losses. Learn how to use the Zen Ratings to find stocks that enjoy more consistent growth…and more consistent outperformance.
2 months ago•Steve Reitmeister
NVDA
SRPT
SG
LCID
5 Stocks to Watch: Week of 1/5/2026
5 stocks to watch for the week of 1/5, including DNow (DNOW) and more.
2 months ago•Jessie Moore
DNOW
CRTO
EME
ENS
FTI
3 Credit Service Stocks that Could Serve Your Portfolio
3 solid stocks in a solid industry, including Oppfi (OPFI) and more.
2 months ago•Lyndon Seitz
OPFI
EZPW
OPRT
3 New Strong Buy Ratings from Top-Rated Analysts: 01/02/2026
3 high-potential stock picks for the new year, including Betterware de Mexico Sapi (BWMX) and 2 more.
2 months ago•Jessie Moore
DNOW
CRTO
BWMX
Hot or Not, Stock Market Edition: 01/02/2026
Here’s what’s uptrending and downtrending in the market, expressed through 2 recent upgrades and 2 recent downgrades in our Zen Ratings system.
2 months ago•Jessie Moore
BTG
GTEC
ALK
TXRH
Hot or Not, Stock Market Edition: 01/01/2026
What’s hot and what’s not going into the new year, including pharma play GSK and more.
2 months ago•Jessie Moore
GSK
CI
CAG
O
This “Boring” Stock Keeps Winning (And Growing)
Some of the best-performing stocks don’t look exciting at all.
2 months ago•Corbin Buff
NVT
3 New Strong Buy Ratings from Top-Rated Analysts: 01/01/2026
Spotlighting 3 of our top-performing Zen Investor stocks of 2025 — they’re all still Buy rated.
2 months ago•Jessie Moore
KGC
TPR
EME
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.